palmarumycin cp(1) has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burke-Gaffney, A; Callister, ME; Nakamura, H | 1 |
Birmingham, A; Kirkpatrick, DL; Lynch, SM; Powis, G; Wipf, P | 1 |
1 review(s) available for palmarumycin cp(1) and Neoplasms
Article | Year |
---|---|
Thioredoxin: friend or foe in human disease?
Topics: Cardiovascular Diseases; Dioxanes; Humans; Molecular Structure; Naphthalenes; Neoplasms; Pyridazines; Spiro Compounds; Thioredoxins; Triazoles | 2005 |
1 other study(ies) available for palmarumycin cp(1) and Neoplasms
Article | Year |
---|---|
Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dioxanes; Enzyme Inhibitors; Glycine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Naphthalenes; Neoplasms; Spiro Compounds; Thioredoxin Reductase 1; Thioredoxin-Disulfide Reductase; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2006 |